PRM-151 therapy well tolerated in patients with advanced myelofibrosis
Tuesday, December 9, 2014 - 16:33
in Health & Medicine
A study that investigated the potential of the compound PRM-151 (PRM) for reducing progressive bone marrow fibrosis (scarring) in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.